angiotensin ii Search Results


93
MedChemExpress angiotensin ii human
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Angiotensin Ii Human, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II+human/pm37446016-374-6-0
Average 93 stars, based on 1 article reviews
angiotensin ii human - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Alomone Labs ang ii
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Ang Ii, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II/bio_rxiv__64898__2026__05__28__728606-181-4-6
Average 94 stars, based on 1 article reviews
ang ii - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
OriGene human at1r cdna
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Human At1r Cdna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II+Type+1+Receptor+(AGTR1)+(NM_004835)+Human+Tagged+ORF+Clone/10__1074_slash_jbc__m116__750380-155-5-11
Average 90 stars, based on 1 article reviews
human at1r cdna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
Thermo Fisher ang ii
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Ang Ii, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II/pm41392291-98-27-38
Average 95 stars, based on 1 article reviews
ang ii - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

93
Tocris tocris 1158 atosiban
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Tocris 1158 Atosiban, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II/piegsa_judith__2020__functional_characterisation_of_neurovascular_components_in_physiological_and_pathological_conditions-941-19-19
Average 93 stars, based on 1 article reviews
tocris 1158 atosiban - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
Tocris angiotensin ii
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Angiotensin Ii, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II/bio_rxiv__2020__07__15__205229-89-19-21
Average 95 stars, based on 1 article reviews
angiotensin ii - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

93
Proteintech anti human angiotensin
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Anti Human Angiotensin, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensinogen+Antibody/pm33995679-60-33-38
Average 93 stars, based on 1 article reviews
anti human angiotensin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology ang ii
Figure 1. Effect of administration of uric acid on the release of <t>Ang</t> <t>II</t> from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.
Ang Ii, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II/10__1161_slash_01__CIR__101__10__1130-59-3-53
Average 93 stars, based on 1 article reviews
ang ii - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

98
MedChemExpress angiotensin ii
The protective role of atRA in heart failure. A , α-Actinin staining was performed to identify NRCMs. Representative images and quantification of cell size of total 30 microscope fields in each group (group1: NRCMs, group2: NRCMs treated with atRA, group3: NRCM stimulated with Ang II, and group4: NRCM stimulated with <t>Ang</t> <t>II</t> then treated with atRA) are shown. B , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 4 biological replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. C , the cluster heatmaps indicate the expression patterns of two cluster of proteins detected in NRCM under different conditions (Ang II nonstimulate, Ang II stimulated, Ang II stimulated with atRA treatment). The color bar indicates normalized z-scored iBAQ. The top GOBP terms enriched by each cluster are shown on the right . D , representative global heart photographs of four mice are shown (scale bar represents 2 mm). E , the bar plot shows the heart weight/tibia, heart rate, LV ejection fraction, fractional shortening, LV internal dimension at end-diastole, LV internal dimension at end-systole, LV anterior wall thickness at end-diastole, LV posterior wall thickness at end-systole, all measurements are shown as mean ± SEM. n = 7 biological replicates in Sham group and n = 8 biological replicates in TAC group. F , Masson staining showed strong fibrosis in ventricular regions. Scale bars represent 100 μm. G , the mRNA levels of Ctgf, Cola1 , and Col3a1 were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. H , hematoxylin-eosin (H&E, scale bar = 1 mm) staining and wheat germ agglutinin (WGA, scale bar = 30 μm) staining were performed to determine the hypertrophic degree of the hearts. I , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. J , the bar plot indicates the GOBP enriched in the proteins upregulated in TAC group ( orange ) and downregulated in TAC group ( green ), compared with sham oil group. K , the bar plot shows the GOBP enriched by the proteins upregulated in TAC mice treated with atRA ( orange ) and downregulated in TAC mice treated with atRA ( green ), compared with TAC oil group. L , the western blots show the expression patterns of Rxra, Rxrb, and Gapdh in the four groups (group1: WT mice treated with corn oil, group2: TAC mice treated with corn oil, group3: WT mice treated with atRA, Group4: TAC mice treated with atRA). M , The mRNA level of Rxra and Rxrb were determined using qRT-PCR. n = 7 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. N , the hypothetical mechanism of atRA rescuing heart from cardiac hypertrophy. Under physiological conditions, retinol is oxidized to retinaldehyde by either alcohol dehydrogenase or retinol dehydrogenase (RDH), and retinaldehyde is oxidized to RA by aldehyde dehydrogenase (ALDH). RA is then released and taken up by cardiomyocytes and cellular-RA–binding protein (CRABP) facilitates RA to transport to the nucleus where RA can bind the RA receptor (RAR). When mouse is treated with atRA (60 mg/kg/day) for 4 weeks after TAC surgery, cardiac hypertrophy is relieved. The atRA may act through the activation of Rxr family and maintains cardiac function.
Angiotensin Ii, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II+human/pmc12139502-37-44-46
Average 98 stars, based on 1 article reviews
angiotensin ii - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

93
ALPCO plasma ang ii concentrations
The protective role of atRA in heart failure. A , α-Actinin staining was performed to identify NRCMs. Representative images and quantification of cell size of total 30 microscope fields in each group (group1: NRCMs, group2: NRCMs treated with atRA, group3: NRCM stimulated with Ang II, and group4: NRCM stimulated with <t>Ang</t> <t>II</t> then treated with atRA) are shown. B , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 4 biological replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. C , the cluster heatmaps indicate the expression patterns of two cluster of proteins detected in NRCM under different conditions (Ang II nonstimulate, Ang II stimulated, Ang II stimulated with atRA treatment). The color bar indicates normalized z-scored iBAQ. The top GOBP terms enriched by each cluster are shown on the right . D , representative global heart photographs of four mice are shown (scale bar represents 2 mm). E , the bar plot shows the heart weight/tibia, heart rate, LV ejection fraction, fractional shortening, LV internal dimension at end-diastole, LV internal dimension at end-systole, LV anterior wall thickness at end-diastole, LV posterior wall thickness at end-systole, all measurements are shown as mean ± SEM. n = 7 biological replicates in Sham group and n = 8 biological replicates in TAC group. F , Masson staining showed strong fibrosis in ventricular regions. Scale bars represent 100 μm. G , the mRNA levels of Ctgf, Cola1 , and Col3a1 were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. H , hematoxylin-eosin (H&E, scale bar = 1 mm) staining and wheat germ agglutinin (WGA, scale bar = 30 μm) staining were performed to determine the hypertrophic degree of the hearts. I , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. J , the bar plot indicates the GOBP enriched in the proteins upregulated in TAC group ( orange ) and downregulated in TAC group ( green ), compared with sham oil group. K , the bar plot shows the GOBP enriched by the proteins upregulated in TAC mice treated with atRA ( orange ) and downregulated in TAC mice treated with atRA ( green ), compared with TAC oil group. L , the western blots show the expression patterns of Rxra, Rxrb, and Gapdh in the four groups (group1: WT mice treated with corn oil, group2: TAC mice treated with corn oil, group3: WT mice treated with atRA, Group4: TAC mice treated with atRA). M , The mRNA level of Rxra and Rxrb were determined using qRT-PCR. n = 7 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. N , the hypothetical mechanism of atRA rescuing heart from cardiac hypertrophy. Under physiological conditions, retinol is oxidized to retinaldehyde by either alcohol dehydrogenase or retinol dehydrogenase (RDH), and retinaldehyde is oxidized to RA by aldehyde dehydrogenase (ALDH). RA is then released and taken up by cardiomyocytes and cellular-RA–binding protein (CRABP) facilitates RA to transport to the nucleus where RA can bind the RA receptor (RAR). When mouse is treated with atRA (60 mg/kg/day) for 4 weeks after TAC surgery, cardiac hypertrophy is relieved. The atRA may act through the activation of Rxr family and maintains cardiac function.
Plasma Ang Ii Concentrations, supplied by ALPCO, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II+ELISA/pmc03625779-193-22-31
Average 93 stars, based on 1 article reviews
plasma ang ii concentrations - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Novus Biologicals anti ang ii antibody
The protective role of atRA in heart failure. A , α-Actinin staining was performed to identify NRCMs. Representative images and quantification of cell size of total 30 microscope fields in each group (group1: NRCMs, group2: NRCMs treated with atRA, group3: NRCM stimulated with Ang II, and group4: NRCM stimulated with <t>Ang</t> <t>II</t> then treated with atRA) are shown. B , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 4 biological replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. C , the cluster heatmaps indicate the expression patterns of two cluster of proteins detected in NRCM under different conditions (Ang II nonstimulate, Ang II stimulated, Ang II stimulated with atRA treatment). The color bar indicates normalized z-scored iBAQ. The top GOBP terms enriched by each cluster are shown on the right . D , representative global heart photographs of four mice are shown (scale bar represents 2 mm). E , the bar plot shows the heart weight/tibia, heart rate, LV ejection fraction, fractional shortening, LV internal dimension at end-diastole, LV internal dimension at end-systole, LV anterior wall thickness at end-diastole, LV posterior wall thickness at end-systole, all measurements are shown as mean ± SEM. n = 7 biological replicates in Sham group and n = 8 biological replicates in TAC group. F , Masson staining showed strong fibrosis in ventricular regions. Scale bars represent 100 μm. G , the mRNA levels of Ctgf, Cola1 , and Col3a1 were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. H , hematoxylin-eosin (H&E, scale bar = 1 mm) staining and wheat germ agglutinin (WGA, scale bar = 30 μm) staining were performed to determine the hypertrophic degree of the hearts. I , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. J , the bar plot indicates the GOBP enriched in the proteins upregulated in TAC group ( orange ) and downregulated in TAC group ( green ), compared with sham oil group. K , the bar plot shows the GOBP enriched by the proteins upregulated in TAC mice treated with atRA ( orange ) and downregulated in TAC mice treated with atRA ( green ), compared with TAC oil group. L , the western blots show the expression patterns of Rxra, Rxrb, and Gapdh in the four groups (group1: WT mice treated with corn oil, group2: TAC mice treated with corn oil, group3: WT mice treated with atRA, Group4: TAC mice treated with atRA). M , The mRNA level of Rxra and Rxrb were determined using qRT-PCR. n = 7 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. N , the hypothetical mechanism of atRA rescuing heart from cardiac hypertrophy. Under physiological conditions, retinol is oxidized to retinaldehyde by either alcohol dehydrogenase or retinol dehydrogenase (RDH), and retinaldehyde is oxidized to RA by aldehyde dehydrogenase (ALDH). RA is then released and taken up by cardiomyocytes and cellular-RA–binding protein (CRABP) facilitates RA to transport to the nucleus where RA can bind the RA receptor (RAR). When mouse is treated with atRA (60 mg/kg/day) for 4 weeks after TAC surgery, cardiac hypertrophy is relieved. The atRA may act through the activation of Rxr family and maintains cardiac function.
Anti Ang Ii Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II%2FIII+Antibody+(Ang+II+E7+(BGN%2FKA%2F4L))+-+BSA+Free/pm41619334-90-20-23
Average 94 stars, based on 1 article reviews
anti ang ii antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
Novus Biologicals rabbit anti angiotensin ii type i
The protective role of atRA in heart failure. A , α-Actinin staining was performed to identify NRCMs. Representative images and quantification of cell size of total 30 microscope fields in each group (group1: NRCMs, group2: NRCMs treated with atRA, group3: NRCM stimulated with Ang II, and group4: NRCM stimulated with <t>Ang</t> <t>II</t> then treated with atRA) are shown. B , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 4 biological replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. C , the cluster heatmaps indicate the expression patterns of two cluster of proteins detected in NRCM under different conditions (Ang II nonstimulate, Ang II stimulated, Ang II stimulated with atRA treatment). The color bar indicates normalized z-scored iBAQ. The top GOBP terms enriched by each cluster are shown on the right . D , representative global heart photographs of four mice are shown (scale bar represents 2 mm). E , the bar plot shows the heart weight/tibia, heart rate, LV ejection fraction, fractional shortening, LV internal dimension at end-diastole, LV internal dimension at end-systole, LV anterior wall thickness at end-diastole, LV posterior wall thickness at end-systole, all measurements are shown as mean ± SEM. n = 7 biological replicates in Sham group and n = 8 biological replicates in TAC group. F , Masson staining showed strong fibrosis in ventricular regions. Scale bars represent 100 μm. G , the mRNA levels of Ctgf, Cola1 , and Col3a1 were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. H , hematoxylin-eosin (H&E, scale bar = 1 mm) staining and wheat germ agglutinin (WGA, scale bar = 30 μm) staining were performed to determine the hypertrophic degree of the hearts. I , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. J , the bar plot indicates the GOBP enriched in the proteins upregulated in TAC group ( orange ) and downregulated in TAC group ( green ), compared with sham oil group. K , the bar plot shows the GOBP enriched by the proteins upregulated in TAC mice treated with atRA ( orange ) and downregulated in TAC mice treated with atRA ( green ), compared with TAC oil group. L , the western blots show the expression patterns of Rxra, Rxrb, and Gapdh in the four groups (group1: WT mice treated with corn oil, group2: TAC mice treated with corn oil, group3: WT mice treated with atRA, Group4: TAC mice treated with atRA). M , The mRNA level of Rxra and Rxrb were determined using qRT-PCR. n = 7 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. N , the hypothetical mechanism of atRA rescuing heart from cardiac hypertrophy. Under physiological conditions, retinol is oxidized to retinaldehyde by either alcohol dehydrogenase or retinol dehydrogenase (RDH), and retinaldehyde is oxidized to RA by aldehyde dehydrogenase (ALDH). RA is then released and taken up by cardiomyocytes and cellular-RA–binding protein (CRABP) facilitates RA to transport to the nucleus where RA can bind the RA receptor (RAR). When mouse is treated with atRA (60 mg/kg/day) for 4 weeks after TAC surgery, cardiac hypertrophy is relieved. The atRA may act through the activation of Rxr family and maintains cardiac function.
Rabbit Anti Angiotensin Ii Type I, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/angiotensin+ii/Angiotensin+II+Antibody+(KAA8)+%5BmFluor+Violet+450+SE%5D/pm31735744-29-3-12
Average 90 stars, based on 1 article reviews
rabbit anti angiotensin ii type i - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Effect of administration of uric acid on the release of Ang II from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.

Journal: International journal of molecular sciences

Article Title: Accumulation of Renal Fibrosis in Hyperuricemia Rats Is Attributed to the Recruitment of Mast Cells, Activation of the TGF-β1/Smad2/3 Pathway, and Aggravation of Oxidative Stress.

doi: 10.3390/ijms241310839

Figure Lengend Snippet: Figure 1. Effect of administration of uric acid on the release of Ang II from RBL-2H3 cells. (A,B): The viability of RBL-2H3 cells was determined via CCK-8 assay after treatment with various uric acid concentrations for 24 h or 48 h. (C): Toluidine blue staining of RBL-2H3 after treatment with various uric acid concentrations for 24 h or 48 h. Scale bar = 50 µm. (D,E): Ang II levels in each group after treatment with various uric acid concentrations for 24 h or 48 h. Results are shown as mean ± S.D. (n = 4). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group.

Article Snippet: MedChemExpress (Monmouth Junction, NJ, USA) supplied Angiotensin II human.

Techniques: CCK-8 Assay, Staining, Control

Figure 8. Effects of SCG or VAL on renal oxidative stress in hyperuricemic rats. (A–D): Renal GSH level, renal GSH-Px activity, renal GR activity, and renal MDA level in each group. (E): Serum Ang II level in each group. (F,G): The viability of HK-2 cells was determined via CCK-8 assay after treatment with various Ang II concentrations for 24 h or 48 h. (H): Reactive oxygen species (ROS) levels in each group after incubation of HK-2 cells with different concentrations of Ang II for 24 or 48 h (100×). Results are shown as mean ± S.D. (n = 6). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group. # p < 0.05, ## p < 0.01 indicate statistically significant differences compared with the model group.

Journal: International journal of molecular sciences

Article Title: Accumulation of Renal Fibrosis in Hyperuricemia Rats Is Attributed to the Recruitment of Mast Cells, Activation of the TGF-β1/Smad2/3 Pathway, and Aggravation of Oxidative Stress.

doi: 10.3390/ijms241310839

Figure Lengend Snippet: Figure 8. Effects of SCG or VAL on renal oxidative stress in hyperuricemic rats. (A–D): Renal GSH level, renal GSH-Px activity, renal GR activity, and renal MDA level in each group. (E): Serum Ang II level in each group. (F,G): The viability of HK-2 cells was determined via CCK-8 assay after treatment with various Ang II concentrations for 24 h or 48 h. (H): Reactive oxygen species (ROS) levels in each group after incubation of HK-2 cells with different concentrations of Ang II for 24 or 48 h (100×). Results are shown as mean ± S.D. (n = 6). * p < 0.05, ** p < 0.01 indicate statistically significant differences compared with the control group. # p < 0.05, ## p < 0.01 indicate statistically significant differences compared with the model group.

Article Snippet: MedChemExpress (Monmouth Junction, NJ, USA) supplied Angiotensin II human.

Techniques: Activity Assay, CCK-8 Assay, Incubation, Control

The protective role of atRA in heart failure. A , α-Actinin staining was performed to identify NRCMs. Representative images and quantification of cell size of total 30 microscope fields in each group (group1: NRCMs, group2: NRCMs treated with atRA, group3: NRCM stimulated with Ang II, and group4: NRCM stimulated with Ang II then treated with atRA) are shown. B , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 4 biological replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. C , the cluster heatmaps indicate the expression patterns of two cluster of proteins detected in NRCM under different conditions (Ang II nonstimulate, Ang II stimulated, Ang II stimulated with atRA treatment). The color bar indicates normalized z-scored iBAQ. The top GOBP terms enriched by each cluster are shown on the right . D , representative global heart photographs of four mice are shown (scale bar represents 2 mm). E , the bar plot shows the heart weight/tibia, heart rate, LV ejection fraction, fractional shortening, LV internal dimension at end-diastole, LV internal dimension at end-systole, LV anterior wall thickness at end-diastole, LV posterior wall thickness at end-systole, all measurements are shown as mean ± SEM. n = 7 biological replicates in Sham group and n = 8 biological replicates in TAC group. F , Masson staining showed strong fibrosis in ventricular regions. Scale bars represent 100 μm. G , the mRNA levels of Ctgf, Cola1 , and Col3a1 were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. H , hematoxylin-eosin (H&E, scale bar = 1 mm) staining and wheat germ agglutinin (WGA, scale bar = 30 μm) staining were performed to determine the hypertrophic degree of the hearts. I , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. J , the bar plot indicates the GOBP enriched in the proteins upregulated in TAC group ( orange ) and downregulated in TAC group ( green ), compared with sham oil group. K , the bar plot shows the GOBP enriched by the proteins upregulated in TAC mice treated with atRA ( orange ) and downregulated in TAC mice treated with atRA ( green ), compared with TAC oil group. L , the western blots show the expression patterns of Rxra, Rxrb, and Gapdh in the four groups (group1: WT mice treated with corn oil, group2: TAC mice treated with corn oil, group3: WT mice treated with atRA, Group4: TAC mice treated with atRA). M , The mRNA level of Rxra and Rxrb were determined using qRT-PCR. n = 7 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. N , the hypothetical mechanism of atRA rescuing heart from cardiac hypertrophy. Under physiological conditions, retinol is oxidized to retinaldehyde by either alcohol dehydrogenase or retinol dehydrogenase (RDH), and retinaldehyde is oxidized to RA by aldehyde dehydrogenase (ALDH). RA is then released and taken up by cardiomyocytes and cellular-RA–binding protein (CRABP) facilitates RA to transport to the nucleus where RA can bind the RA receptor (RAR). When mouse is treated with atRA (60 mg/kg/day) for 4 weeks after TAC surgery, cardiac hypertrophy is relieved. The atRA may act through the activation of Rxr family and maintains cardiac function.

Journal: Molecular & Cellular Proteomics : MCP

Article Title: Region- and Cell-type–Resolved Multiomic Atlas of the Heart

doi: 10.1016/j.mcpro.2025.100922

Figure Lengend Snippet: The protective role of atRA in heart failure. A , α-Actinin staining was performed to identify NRCMs. Representative images and quantification of cell size of total 30 microscope fields in each group (group1: NRCMs, group2: NRCMs treated with atRA, group3: NRCM stimulated with Ang II, and group4: NRCM stimulated with Ang II then treated with atRA) are shown. B , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 4 biological replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. C , the cluster heatmaps indicate the expression patterns of two cluster of proteins detected in NRCM under different conditions (Ang II nonstimulate, Ang II stimulated, Ang II stimulated with atRA treatment). The color bar indicates normalized z-scored iBAQ. The top GOBP terms enriched by each cluster are shown on the right . D , representative global heart photographs of four mice are shown (scale bar represents 2 mm). E , the bar plot shows the heart weight/tibia, heart rate, LV ejection fraction, fractional shortening, LV internal dimension at end-diastole, LV internal dimension at end-systole, LV anterior wall thickness at end-diastole, LV posterior wall thickness at end-systole, all measurements are shown as mean ± SEM. n = 7 biological replicates in Sham group and n = 8 biological replicates in TAC group. F , Masson staining showed strong fibrosis in ventricular regions. Scale bars represent 100 μm. G , the mRNA levels of Ctgf, Cola1 , and Col3a1 were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. H , hematoxylin-eosin (H&E, scale bar = 1 mm) staining and wheat germ agglutinin (WGA, scale bar = 30 μm) staining were performed to determine the hypertrophic degree of the hearts. I , the boxplot shows the myocyte cross-sectional area in the four groups. The mRNA levels of hypertrophic genes ( Anp, Bnp ) were determined using qRT-PCR. n = 6 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. J , the bar plot indicates the GOBP enriched in the proteins upregulated in TAC group ( orange ) and downregulated in TAC group ( green ), compared with sham oil group. K , the bar plot shows the GOBP enriched by the proteins upregulated in TAC mice treated with atRA ( orange ) and downregulated in TAC mice treated with atRA ( green ), compared with TAC oil group. L , the western blots show the expression patterns of Rxra, Rxrb, and Gapdh in the four groups (group1: WT mice treated with corn oil, group2: TAC mice treated with corn oil, group3: WT mice treated with atRA, Group4: TAC mice treated with atRA). M , The mRNA level of Rxra and Rxrb were determined using qRT-PCR. n = 7 biologically replicates for each group. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant. N , the hypothetical mechanism of atRA rescuing heart from cardiac hypertrophy. Under physiological conditions, retinol is oxidized to retinaldehyde by either alcohol dehydrogenase or retinol dehydrogenase (RDH), and retinaldehyde is oxidized to RA by aldehyde dehydrogenase (ALDH). RA is then released and taken up by cardiomyocytes and cellular-RA–binding protein (CRABP) facilitates RA to transport to the nucleus where RA can bind the RA receptor (RAR). When mouse is treated with atRA (60 mg/kg/day) for 4 weeks after TAC surgery, cardiac hypertrophy is relieved. The atRA may act through the activation of Rxr family and maintains cardiac function.

Article Snippet: NRCMs were isolated from 1 to 3 days old Sprague-Dawley rats and cultured in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F12) (Invitrogen, 11330032) with 10% fetal bovine serum for 24 h. Then medium was changed into serum-free DMEM/F12 for 24 h. One micromolar of Angiotensin II (MCE, HY- 13948) treated cells individually or treated cells with 1 μM atRA (Sigma, R2625) collectively for 24 h. After 24 h incubation, cardiomyocytes were collected and lysed for further quantitative real-time PCR (qRT-PCR).

Techniques: Staining, Microscopy, Quantitative RT-PCR, Expressing, Western Blot, Binding Assay, Activation Assay